Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Warts 2Hyperthermia 2Breast Neoplasms 2Carcinoma, Basal Cell 1

Interventions

Cryotherapy 11resiquimod 6Cantharidin 5PRA1 protein, Candida albicans 4Tuberculin 3Salicylic Acid 3Cholecalciferol 3plerixafor 2VP-102 2Solutions 2Sodium Chloride 2Saline Solution 2Photochemotherapy 2Percutaneous Collagen Induction 2N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Measles-Mumps-Rubella Vaccine 2Lasers 2Hydrogen Peroxide 2Human Papillomavirus Recombinant Vaccine nonavalent 23-ingenyl angelate 22-Propanol 2methyl 5-aminolevulinate 1lactic acid, salicylic acid drug combination 1human papillomavirus vaccine, L1 type 16, 18 1green tea extract polyphenone E 1gluconic acid 1ethyl pyruvate 1compound W 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1Zinc Sulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Warts × Hydrogen Peroxide × Clear all
NCT07565350 2026-05-04

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

First Hospital of China Medical University

Phase NA Recruiting
80 enrolled

Hyperthermia, Warts

NCT06812065 2025-02-06

Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts

First Hospital of China Medical University

Phase NA Recruiting
300 enrolled

Hyperthermia, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡